C20orf135 Activators
These compounds collectively represent a class of C20orf135 Activators that function through indirect mechanisms to upregulate the expression or activity of the ABHD16B protein. This class encompasses a variety of small molecules that influence cellular signaling cascades and transcriptional regulation processes.
The chemical class of C20orf135 Activators is characterized by the ability to modulate intracellular signaling pathways and influence transcription factor activity, leading to changes in gene expression. These molecules, ranging from forskolin, which targets cAMP synthesis, to specific agonists for nuclear receptors like PPARs and LXRs, manipulate cellular regulatory networks that can culminate in the increased expression of ABHD16B. The compounds operate through distinct molecular mechanisms, including direct receptor activation, inhibition of enzyme activity, or epigenetic modulation, indicating a diverse chemical and functional spectrum. The inclusion of a cGMP analog points to secondary messenger systems as regulatory mechanisms, while insulin mimetics and GLP-1 analogs highlight the importance of metabolic signaling in modulating gene expression. Sirtuin activators like resveratrol further suggest that post-translational modifications of histones and transcription factors are also critical in the regulation of genes related to ABHD16B expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
All-trans retinoic acid is a metabolite of vitamin A that serves as an agonist to retinoic acid receptors (RARs). RARs, upon binding to retinoic acid, can regulate gene expression by binding to retinoic acid response elements in the promoters of target genes, potentially including ABHD16B if it is RAR-responsive. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate is a PPARα agonist that can regulate gene expression by activating peroxisome proliferator-activated receptors, which may lead to transcriptional activation of genes involved in lipid metabolism, potentially including ABHD16B. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), a sensor of cellular energy status. Upon activation, AMPK can initiate a cascade of events leading to changes in gene expression and cellular metabolism, which could include an increase in ABHD16B expression if it is involved in these metabolic processes. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol is a phosphodiesterase III inhibitor that leads to increased cAMP levels by preventing its degradation. The subsequent activation of PKA could result in the upregulation of ABHD16B expression, provided that the ABHD16B gene promoter is sensitive to cAMP-mediated signaling. | ||||||
GW3965 | 405911-09-3 | sc-490151 sc-490151A sc-490151B | 10 mg 50 mg 1 g | $260.00 $872.00 $1637.00 | ||
GW3965 is an LXR agonist that can influence gene expression related to cholesterol homeostasis. Activation of LXR can lead to an upregulation of genes in this pathway, which may include ABHD16B if it is involved in cholesterol regulation. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone is a PPARγ agonist with insulin-sensitizing effects. It can modulate the transcription of insulin-responsive genes, potentially leading to an upregulation of ABHD16B if it plays a role in insulin-mediated metabolic processes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is known to activate sirtuin 1 (SIRT1), which is involved in deacetylating transcription factors and histones, leading to alterations in gene expression. If ABHD16B expression is regulated by such mechanisms, resveratrol could play a role in its upregulation. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $62.00 | ||
L-Leucine can activate the mammalian target of rapamycin (mTOR) pathway, which plays a critical role in regulating protein synthesis and cellular metabolism. If ABHD16B is part of these pathways, its expression may be influenced by L-Leucine. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cGMP) is a stable analog of cGMP that can serve as a secondary messenger, potentially regulating gene expression. If ABHD16B is part of the signaling networks influenced by cGMP, 8-Br-cGMP may lead to its increased expression. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic acid has been shown to inhibit histone acetyltransferase activities and can also modulate histone methylation patterns. This could lead to epigenetic changes in gene expression profiles, potentially influencing the expression of ABHD16B. | ||||||